INOVIO PHARMACEUTICALS, INC. Quarterly Amortization of Intangible Assets in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Inovio Pharmaceuticals, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2011 to Q1 2024.
  • Inovio Pharmaceuticals, Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Inovio Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2023 was $145K, a 70.7% decline from 2022.
  • Inovio Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2022 was $496K, a 4.6% decline from 2021.
  • Inovio Pharmaceuticals, Inc. annual Amortization of Intangible Assets for 2021 was $520K, a 4.87% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $0 -$82.1K -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q1 2023 $452K $82.1K -$44.7K -35.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $496K $119K -$7.92K -6.25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $504K $120K -$7K -5.51% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $511K $131K +$1K +0.77% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $510K $127K -$10K -7.31% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $520K $127K -$9.67K -7.09% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $530K $127K -$10K -7.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $540K $130K -$7K -5.11% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $547K $137K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $547K $136K -$129K -48.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $677K $137K -$130K -48.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $807K $137K -$130K -48.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $937K $137K -$130K -48.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $1.07M $266K -$791 -0.3% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.07M $267K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.07M $267K -$45K -14.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.11M $267K -$137K -34% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.25M $267K -$138K -34.1% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $1.39M $267K -$137K -33.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.52M $312K -$92K -22.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $1.62M $404K -$2.24K -0.55% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $1.62M $404K -$4.56K -1.12% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $1.62M $404K -$8K -1.94% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $1.63M $404K +$57K +16.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $1.57M $406K +$197K +93.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $1.38M $409K +$196K +92.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $1.18M $412K +$197K +91.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $984K $347K +$128K +58.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $856K $210K -$13.9K -6.24% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $870K $213K -$17.2K -7.48% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $887K $215K -$20K -8.51% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $907K $219K -$19K -7.98% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $926K $223K -$16.3K -6.81% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $943K $230K -$208K -47.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $1.15M $235K -$205K -46.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.36M $238K -$207K -46.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $1.56M $240K -$208K -46.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 $1.77M $438K -$12.9K -2.87% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-14
Q3 2013 $1.78M $440K -$13K -2.87% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $1.8M $445K -$12K -2.63% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $1.81M $448K -$12.7K -2.76% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 $1.82M $451K -$25.5K -5.35% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 $1.85M $453K $0 0% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.85M $457K -$12K -2.56% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 $1.86M $461K -$10.9K -2.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $1.87M $476K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $453K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 $469K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $471K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.